vs
RESOURCES CONNECTION, INC.（RGP）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$117.7M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -10.8%，领先394.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -19.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -11.8%）
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
RGP vs RIGL — 直观对比
营收规模更大
RGP
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出40.3%
-19.2%
净利率更高
RIGL
高出394.8%
-10.8%
两年增速更快
RIGL
近两年复合增速
-11.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $69.8M |
| 净利润 | $-12.7M | $268.1M |
| 毛利率 | 37.1% | 91.5% |
| 营业利润率 | -10.3% | 33.2% |
| 净利率 | -10.8% | 384.0% |
| 营收同比 | -19.2% | 21.2% |
| 净利润同比 | 81.6% | 1769.2% |
| 每股收益（稀释后） | $-0.38 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RGPRIGL
| Q4 25 | $117.7M | $69.8M | ||
| Q3 25 | $120.2M | $69.5M | ||
| Q2 25 | $139.3M | $101.7M | ||
| Q1 25 | $129.4M | $53.3M | ||
| Q4 24 | $145.6M | $57.6M | ||
| Q3 24 | $136.9M | $55.3M | ||
| Q2 24 | $148.2M | $36.8M | ||
| Q1 24 | $151.3M | $29.5M |
净利润RGPRIGL
| Q4 25 | $-12.7M | $268.1M | ||
| Q3 25 | $-2.4M | $27.9M | ||
| Q2 25 | $-73.3M | $59.6M | ||
| Q1 25 | $-44.1M | $11.4M | ||
| Q4 24 | $-68.7M | $14.3M | ||
| Q3 24 | $-5.7M | $12.4M | ||
| Q2 24 | $10.5M | $-1.0M | ||
| Q1 24 | $2.5M | $-8.2M |
毛利率RGPRIGL
| Q4 25 | 37.1% | 91.5% | ||
| Q3 25 | 39.5% | 93.2% | ||
| Q2 25 | 40.2% | 95.6% | ||
| Q1 25 | 35.1% | 91.7% | ||
| Q4 24 | 38.5% | 89.9% | ||
| Q3 24 | 36.5% | 85.5% | ||
| Q2 24 | 40.2% | 92.4% | ||
| Q1 24 | 37.0% | 93.1% |
营业利润率RGPRIGL
| Q4 25 | -10.3% | 33.2% | ||
| Q3 25 | -1.7% | 40.9% | ||
| Q2 25 | -47.0% | 60.1% | ||
| Q1 25 | -38.4% | 23.9% | ||
| Q4 24 | -52.7% | 28.9% | ||
| Q3 24 | -3.5% | 25.4% | ||
| Q2 24 | 7.6% | 1.2% | ||
| Q1 24 | 2.8% | -23.6% |
净利率RGPRIGL
| Q4 25 | -10.8% | 384.0% | ||
| Q3 25 | -2.0% | 40.2% | ||
| Q2 25 | -52.6% | 58.6% | ||
| Q1 25 | -34.0% | 21.5% | ||
| Q4 24 | -47.2% | 24.9% | ||
| Q3 24 | -4.2% | 22.5% | ||
| Q2 24 | 7.1% | -2.8% | ||
| Q1 24 | 1.7% | -27.9% |
每股收益（稀释后）RGPRIGL
| Q4 25 | $-0.38 | $14.11 | ||
| Q3 25 | $-0.07 | $1.46 | ||
| Q2 25 | $-2.21 | $3.28 | ||
| Q1 25 | $-1.34 | $0.63 | ||
| Q4 24 | $-2.08 | $0.82 | ||
| Q3 24 | $-0.17 | $0.70 | ||
| Q2 24 | $0.31 | $-0.06 | ||
| Q1 24 | $0.08 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.8M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $194.6M | $391.5M |
| 总资产 | $289.3M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资RGPRIGL
| Q4 25 | $89.8M | $155.0M | ||
| Q3 25 | $77.5M | $137.1M | ||
| Q2 25 | $86.1M | $108.4M | ||
| Q1 25 | $72.5M | $77.1M | ||
| Q4 24 | $78.2M | $77.3M | ||
| Q3 24 | $89.6M | $61.1M | ||
| Q2 24 | $108.9M | $49.1M | ||
| Q1 24 | $113.8M | $49.5M |
总债务RGPRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益RGPRIGL
| Q4 25 | $194.6M | $391.5M | ||
| Q3 25 | $206.4M | $117.6M | ||
| Q2 25 | $207.1M | $81.9M | ||
| Q1 25 | $277.8M | $18.6M | ||
| Q4 24 | $325.7M | $3.3M | ||
| Q3 24 | $407.2M | $-14.6M | ||
| Q2 24 | $418.8M | $-29.9M | ||
| Q1 24 | $414.9M | $-31.7M |
总资产RGPRIGL
| Q4 25 | $289.3M | $513.6M | ||
| Q3 25 | $287.2M | $242.5M | ||
| Q2 25 | $304.7M | $206.7M | ||
| Q1 25 | $375.6M | $176.0M | ||
| Q4 24 | $424.9M | $164.0M | ||
| Q3 24 | $512.9M | $139.4M | ||
| Q2 24 | $510.9M | $128.4M | ||
| Q1 24 | $523.2M | $126.5M |
负债/权益比RGPRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $15.6M | — |
| 自由现金流率自由现金流/营收 | 13.2% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $24.3M | — |
8季度趋势，按日历期对齐
经营现金流RGPRIGL
| Q4 25 | $15.9M | $22.0M | ||
| Q3 25 | $-7.8M | $24.0M | ||
| Q2 25 | $16.8M | $30.5M | ||
| Q1 25 | $659.0K | $-893.0K | ||
| Q4 24 | $1.8M | $14.5M | ||
| Q3 24 | $-309.0K | $21.7M | ||
| Q2 24 | $3.2M | $302.0K | ||
| Q1 24 | $20.5M | $-5.0M |
自由现金流RGPRIGL
| Q4 25 | $15.6M | — | ||
| Q3 25 | $-8.0M | — | ||
| Q2 25 | $16.5M | — | ||
| Q1 25 | $238.0K | — | ||
| Q4 24 | $61.0K | — | ||
| Q3 24 | $-575.0K | — | ||
| Q2 24 | $3.0M | — | ||
| Q1 24 | $20.4M | — |
自由现金流率RGPRIGL
| Q4 25 | 13.2% | — | ||
| Q3 25 | -6.6% | — | ||
| Q2 25 | 11.8% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | -0.4% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 13.5% | — |
资本支出强度RGPRIGL
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率RGPRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 0.30× | — | ||
| Q1 24 | 8.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
RIGL
暂无分部数据
